Cargando…

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease

OBJECTIVE: To analyze the risk factors of in-stent restenosis (ISR) after the first implantation of drug-eluting stent (DES) patients with coronary heart disease (CHD) and to establish a nomogram model to predict the risk of ISR. METHODS: This study retrospectively analyzed the clinical data of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Hongfei, Liu, Jiasi, Xu, Tao, Li, Zhe, Mou, Xuanting, Jin, Yu, Xia, Shudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035367/
https://www.ncbi.nlm.nih.gov/pubmed/36970340
http://dx.doi.org/10.3389/fcvm.2023.1117915
_version_ 1784911400124022784
author Xi, Hongfei
Liu, Jiasi
Xu, Tao
Li, Zhe
Mou, Xuanting
Jin, Yu
Xia, Shudong
author_facet Xi, Hongfei
Liu, Jiasi
Xu, Tao
Li, Zhe
Mou, Xuanting
Jin, Yu
Xia, Shudong
author_sort Xi, Hongfei
collection PubMed
description OBJECTIVE: To analyze the risk factors of in-stent restenosis (ISR) after the first implantation of drug-eluting stent (DES) patients with coronary heart disease (CHD) and to establish a nomogram model to predict the risk of ISR. METHODS: This study retrospectively analyzed the clinical data of patients with CHD who underwent DES treatment for the first time at the Fourth Affiliated Hospital of Zhejiang University School of Medicine from January 2016 to June 2020. Patients were divided into an ISR group and a non-ISR (N-ISR) group according to the results of coronary angiography. The least absolute shrinkage and selection operator (LASSO) regression analysis was performed on the clinical variables to screen out the characteristic variables. Then we constructed the nomogram prediction model using conditional multivariate logistic regression analysis combined with the clinical variables selected in the LASSO regression analysis. Finally, the decision curve analysis, clinical impact curve, area under the receiver operating characteristic curve, and calibration curve were used to evaluate the nomogram prediction model's clinical applicability, validity, discrimination, and consistency. And we double-validate the prediction model using ten-fold cross-validation and bootstrap validation. RESULTS: In this study, hypertension, HbA1c, mean stent diameter, total stent length, thyroxine, and fibrinogen were all predictive factors for ISR. We successfully constructed a nomogram prediction model using these variables to quantify the risk of ISR. The AUC value of the nomogram prediction model was 0.806 (95%CI: 0.739–0.873), indicating that the model had a good discriminative ability for ISR. The high quality of the calibration curve of the model demonstrated the strong consistency of the model. Moreover, the DCA and CIC curve showed the model's high clinical applicability and effectiveness. CONCLUSIONS: Hypertension, HbA1c, mean stent diameter, total stent length, thyroxine, and fibrinogen are important predictors for ISR. The nomogram prediction model can better identify the high-risk population of ISR and provide practical decision-making information for the follow-up intervention in the high-risk population.
format Online
Article
Text
id pubmed-10035367
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100353672023-03-24 Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease Xi, Hongfei Liu, Jiasi Xu, Tao Li, Zhe Mou, Xuanting Jin, Yu Xia, Shudong Front Cardiovasc Med Cardiovascular Medicine OBJECTIVE: To analyze the risk factors of in-stent restenosis (ISR) after the first implantation of drug-eluting stent (DES) patients with coronary heart disease (CHD) and to establish a nomogram model to predict the risk of ISR. METHODS: This study retrospectively analyzed the clinical data of patients with CHD who underwent DES treatment for the first time at the Fourth Affiliated Hospital of Zhejiang University School of Medicine from January 2016 to June 2020. Patients were divided into an ISR group and a non-ISR (N-ISR) group according to the results of coronary angiography. The least absolute shrinkage and selection operator (LASSO) regression analysis was performed on the clinical variables to screen out the characteristic variables. Then we constructed the nomogram prediction model using conditional multivariate logistic regression analysis combined with the clinical variables selected in the LASSO regression analysis. Finally, the decision curve analysis, clinical impact curve, area under the receiver operating characteristic curve, and calibration curve were used to evaluate the nomogram prediction model's clinical applicability, validity, discrimination, and consistency. And we double-validate the prediction model using ten-fold cross-validation and bootstrap validation. RESULTS: In this study, hypertension, HbA1c, mean stent diameter, total stent length, thyroxine, and fibrinogen were all predictive factors for ISR. We successfully constructed a nomogram prediction model using these variables to quantify the risk of ISR. The AUC value of the nomogram prediction model was 0.806 (95%CI: 0.739–0.873), indicating that the model had a good discriminative ability for ISR. The high quality of the calibration curve of the model demonstrated the strong consistency of the model. Moreover, the DCA and CIC curve showed the model's high clinical applicability and effectiveness. CONCLUSIONS: Hypertension, HbA1c, mean stent diameter, total stent length, thyroxine, and fibrinogen are important predictors for ISR. The nomogram prediction model can better identify the high-risk population of ISR and provide practical decision-making information for the follow-up intervention in the high-risk population. Frontiers Media S.A. 2023-03-10 /pmc/articles/PMC10035367/ /pubmed/36970340 http://dx.doi.org/10.3389/fcvm.2023.1117915 Text en © 2023 Xi, Liu, Xu, Li, Mou, Jin and Xia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Xi, Hongfei
Liu, Jiasi
Xu, Tao
Li, Zhe
Mou, Xuanting
Jin, Yu
Xia, Shudong
Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
title Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
title_full Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
title_fullStr Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
title_full_unstemmed Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
title_short Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
title_sort risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035367/
https://www.ncbi.nlm.nih.gov/pubmed/36970340
http://dx.doi.org/10.3389/fcvm.2023.1117915
work_keys_str_mv AT xihongfei riskinvestigationofinstentrestenosisafterinitialimplantationofintracoronarydrugelutingstentinpatientswithcoronaryheartdisease
AT liujiasi riskinvestigationofinstentrestenosisafterinitialimplantationofintracoronarydrugelutingstentinpatientswithcoronaryheartdisease
AT xutao riskinvestigationofinstentrestenosisafterinitialimplantationofintracoronarydrugelutingstentinpatientswithcoronaryheartdisease
AT lizhe riskinvestigationofinstentrestenosisafterinitialimplantationofintracoronarydrugelutingstentinpatientswithcoronaryheartdisease
AT mouxuanting riskinvestigationofinstentrestenosisafterinitialimplantationofintracoronarydrugelutingstentinpatientswithcoronaryheartdisease
AT jinyu riskinvestigationofinstentrestenosisafterinitialimplantationofintracoronarydrugelutingstentinpatientswithcoronaryheartdisease
AT xiashudong riskinvestigationofinstentrestenosisafterinitialimplantationofintracoronarydrugelutingstentinpatientswithcoronaryheartdisease